昭衍新药
(603127)
| 流通市值：139.97亿 | | | 总市值：166.38亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2025-07-03 | 1001.56万 | 1.90% | 3930.35万 | 7.44% | -261.42万 | -0.49% | -4670.49万 | -8.84% |
| 2025-07-02 | -2560.37万 | -3.63% | -4007.99万 | -5.69% | -2761.23万 | -3.92% | 9329.59万 | 13.24% |
| 2025-07-01 | 2294.19万 | 1.80% | -2203.35万 | -1.73% | -1368.60万 | -1.07% | 1277.77万 | 1.00% |
| 2025-06-30 | 14754.43万 | 15.75% | -11.18万 | -0.01% | -6055.05万 | -6.46% | -8688.20万 | -9.27% |
| 2025-06-27 | 1293.81万 | 3.65% | -1557.97万 | -4.40% | 488.85万 | 1.38% | -224.69万 | -0.63% |
| 2025-06-26 | -2370.28万 | -6.65% | -1503.79万 | -4.22% | -1470.87万 | -4.13% | 5344.94万 | 15.00% |
| 2025-06-25 | -467.70万 | -1.11% | 1240.51万 | 2.94% | -12.04万 | -0.03% | -760.77万 | -1.80% |
| 2025-06-24 | -1230.66万 | -3.12% | 865.41万 | 2.19% | 1227.34万 | 3.11% | -862.09万 | -2.19% |
| 2025-06-23 | 445.00万 | 1.23% | -329.67万 | -0.91% | 917.26万 | 2.53% | -1032.59万 | -2.85% |
| 2025-06-20 | -2057.10万 | -6.84% | 932.85万 | 3.10% | 278.08万 | 0.92% | 846.18万 | 2.81% |